Consequently, pharmacological inhibition of monocyte infiltration by blocking CCR2/CCR5 with Cenicriviroc attenuated disease severity as assessed by serum bile acids, histological severity scoring, and liver fibrosis quantification. Here, CCR2 is linked to Hepatic fibrosis.